earticle

논문검색

Abstracts for poster Presentation

Characterization of Site-Specific N‑Glycopeptide Isoforms of α‑1-Acid Glycoprotein from an Interlaboratory Study Using LC−MS/MS

초록

영어

Glycoprotein conformations are complex and heterogeneous. Currently, site-specific characterization of glycopeptides is a challenge. We sought to establish an efficient method of N-glycoprotein characterization using mass spectrometry (MS). Using alpha-1-acid glycoprotein (AGP) as a model N-glycoprotein, we identified its tryptic N-glycopeptides and examined the data reproducibility in seven laboratories running different LC−MS/MS platforms. We used three test samples and one blind sample to evaluate instrument performance with entire sample preparation workflow. 165 site-specific N-glycopeptides representative of all N-glycosylation sites were identified from AGP 1 and AGP 2 isoforms. The glycopeptide fragmentations by collision-induced dissociation or higher-energy collisional dissociation (HCD) varied based on the MS analyzer. Orbitrap Elite identified the greatest number of AGP N-glycopeptides, followed by Triple TOF and Q-Exactive Plus. Reproducible generation of oxonium ions, glycancleaved glycopeptide fragment ions, and peptide backbone fragment ions was essential for successful identification. Laboratory proficiency affected the number of identified N-glycopeptides. The relative quantities of the 10 major N-glycopeptide isoforms of AGP detected in four laboratories were compared to assess reproducibility. Quantitative analysis showed that the coefficient of variation was <25% for all test samples. Our analytical protocol yielded identification and quantification of site-specific N-glycopeptide isoforms of AGP from control and disease plasma sample.

저자정보

  • Ju Yeon Lee Biomedical Omics Group, Korea Basic Science Institute, Ochang, Republic of Korea
  • Hyun Kyoung Lee Biomedical Omics Group, Korea Basic Science Institute, Ochang, Republic of Korea, Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, Republic of Korea
  • Gun Wook Park Biomedical Omics Group, Korea Basic Science Institute, Ochang, Republic of Korea, Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, Republic of Korea
  • Heeyoun Hwang Biomedical Omics Group, Korea Basic Science Institute, Ochang, Republic of Korea
  • Hoi Keun Jeong Biomedical Omics Group, Korea Basic Science Institute, Ochang, Republic of Korea, Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, Republic of Korea
  • Ki Na Yun Biomedical Omics Group, Korea Basic Science Institute, Ochang, Republic of Korea, Department of Chemistry, Sogang University, Seoul, Republic of Korea
  • Eun SunJ i Biomedical Omics Group, Korea Basic Science Institute, Ochang, Republic of Korea, Department of Chemistry, Hannam University, Daejeon, Republic of Korea
  • Kwang Hoe Kim Biomedical Omics Group, Korea Basic Science Institute, Ochang, Republic of Korea, Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, Republic of Korea
  • Jun Seok Kim Department of Biomedical Systems Engineering, Korea Polytechnics
  • Jong Won Kim New Drug Development Center, Osong Medical Innovation Foundation
  • Sung Ho Yun Drug & Disease Target Group, Korea Basic Science Institute, Daejeon, Republic of Korea
  • Chi-Won Choi Drug & Disease Target Group, Korea Basic Science Institute, Daejeon, Republic of Korea
  • Seung Il Kim Drug & Disease Target Group, Korea Basic Science Institute, Daejeon, Republic of Korea
  • Jong-Sun Lim Yonsei Proteome Research Center, Yonsei University, Seoul, Republic of Korea
  • Seul-Ki Jeong Yonsei Proteome Research Center, Yonsei University, Seoul, Republic of Korea
  • Young-Ki Paik Yonsei Proteome Research Center, Yonsei University, Seoul, Republic of Korea
  • Soo-Youn Lee Department of Laboratory & Genetics, Samsung Medical Center, Sungkyunkwan University of Medicine, Seoul, Korea, Department of Clinical Pharmacology and Therapeutics, Samsung Medical Center, Seoul, South Korea
  • Jisook Park Samsung Biomedical Research Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • Su Yeon Kim Department of Clinical Research Supporting Team, Clinical Research Institute, Samsung Medical Center, Seoul, Korea
  • Young-Jin Choi Department of Biochemistry, BK21 PLUS Program for Creative Veterinary Science Research and Research Institute
  • Yong-In Kim Department of Biochemistry, BK21 PLUS Program for Creative Veterinary Science Research and Research Institute
  • Jawon Seo Department of Biochemistry, BK21 PLUS Program for Creative Veterinary Science Research and Research Institute
  • Je-Yoel Cho Department of Biochemistry, BK21 PLUS Program for Creative Veterinary Science Research and Research Institute
  • Myoung Jin Oh Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, Republic of Korea
  • Nari Seo Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, Republic of Korea
  • Hyun Joo An Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, Republic of Korea
  • Jin Young Kim Biomedical Omics Group, Korea Basic Science Institute, Ochang, Republic of Korea
  • Jong Shin Yoo Biomedical Omics Group, Korea Basic Science Institute, Ochang, Republic of Korea, Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, Republic of Korea

참고문헌

자료제공 : 네이버학술정보

    함께 이용한 논문

      ※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.

      0개의 논문이 장바구니에 담겼습니다.